ІВРЕНЗО

Описание товара

About ІВРЕНЗО

ІВРЕНЗО is a prescription medication containing the active ingredient Roxadustat, used to treat anemia in adult patients with chronic kidney disease (CKD). It is a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that works by stimulating the production of erythropoietin, a hormone that promotes the formation of red blood cells.

Key Benefits & Uses

• Treatment of anemia in adult patients with chronic kidney disease (CKD)
• Stimulation of erythropoiesis (red blood cell production) in the body
• Improvement of hemoglobin levels and reduction of transfusion requirements in patients with CKD

Active Ingredient & Action

Roxadustat, the active ingredient in ІВРЕНЗО, works by inhibiting the activity of prolyl hydroxylase enzymes, which are responsible for the degradation of hypoxia-inducible factor-alpha (HIF-α). This leads to the stabilization of HIF-α and the subsequent increase in erythropoietin production, resulting in the stimulation of red blood cell production in the bone marrow.

Important Notes

ІВРЕНЗО should only be used under the guidance of a healthcare professional and as part of a comprehensive treatment plan for patients with CKD. It is essential to monitor hemoglobin levels regularly and adjust the dosage accordingly to minimize the risk of adverse effects. Patients with a history of cardiovascular disease, hypertension, or other underlying medical conditions should be closely monitored while taking ІВРЕНЗО.